Alkem Laboratories Ltd - Company Profile
Powered by
All the data and insights you need on Alkem Laboratories Ltd in one report.
- Save hours of research time and resources with
our up-to-date Alkem Laboratories Ltd Strategy Report
- Understand Alkem Laboratories Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Alkem Laboratories Ltd (Alkem) develops, manufactures and markets generic and specialty pharmaceutical products. The company’s product portfolio includes active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for acute and chronic diseases such as central nervous system disorders, gastro-intestinal infections, metabolic disorders and diabetes, cancer, skin and hair diseases, urologic diseases, cardiovascular diseases, immune disorders and pain relief. It also offers vitamins, minerals and nutrition products. The company distributes its products directly through its subsidiaries or through a wide network of distributors over more than 40 countries. It also exports products to Germany, Australia, South-East Asia, the US, the UK, Russia-CIS, and Africa. Alkem is headquartered in Mumbai, Maharashtra, India.
Alkem Laboratories Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Therapeutic Areas: | Clavam |
Vitamin and Nutrition | Pan |
Cancer | Pan-D |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | New Products/Services | In May, the company launched Cetuxa, for the treatment of head and neck cancer. |
2023 | New Products/Services | In March, Enzene Biosciences announced the commercial release of its biosimilar for Adalimumab. |
2023 | New Products/Services | In January, the company launched novel antibiotic for Multiple drug resistance (MDR) infections under the brand name Zidavi. |
Competitor Comparison
Key Parameters | Alkem Laboratories Ltd | Sun Pharmaceutical Industries Ltd | Dr. Reddy's Laboratories Ltd | Aurobindo Pharma Ltd | Cipla Ltd |
---|---|---|---|---|---|
Headquarters | India | India | India | India | India |
City | Mumbai | Mumbai | Hyderabad | Hyderabad | Mumbai |
State/Province | Maharashtra | Maharashtra | Telangana | Telangana | Maharashtra |
No. of Employees | 16,871 | 41,000 | 24,832 | 15,690 | 26,615 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Basudeo N. Singh | Chairman | Executive Board | - | - |
Sandeep Singh | Director; Managing Director | Executive Board | 2013 | - |
Nitin Agrawal | Chief Financial Officer | Senior Management | 2024 | - |
Srinivas Singh | Director | Executive Board | 2022 | - |
Madhurima Singh | Director | Executive Board | 2021 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer